Test ID CDTA Carbohydrate Deficient Transferrin, Adult, Serum
Useful For
Indicating chronic alcohol abuse
This test is not appropriate for screening patients for congenital disorders of glycosylation.
Highlights
Patients with chronic alcoholism demonstrate increased levels of carbohydrate deficient transferrin over the amount of normally glycosylated tetrasialotransferrin.
Method Name
Affinity Chromatography/Mass Spectrometry (MS)
Reporting Name
Carb Def Transferrin, Adult, SSpecimen Type
SerumOrdering Guidance
This test is for evaluation of alcohol abuse. If the ordering physician is looking for congenital disorders of glycosylation, order CDG / Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation, Serum.
Necessary Information
1. Patient's age is required.
2. Reason for testing is required if patient is younger than 21 years.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
0.05 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 45 days | |
Refrigerated | 28 days | ||
Ambient | 7 days |
Reference Values
≤0.10
0.11-0.12 (indeterminate)
Day(s) Performed
Wednesday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
82373
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CDTA | Carb Def Transferrin, Adult, S | 53803-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
31714 | Mono-oligo/Di-oligo Ratio | 35469-6 |
31715 | Interpretation | 59462-2 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
3 to 9 daysNY State Approved
YesForms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.